| Morphologic Characteristics of Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study |
|
Leukemia |
Aplastic Anemia |
| The trajectory of prognostication and risk stratification for patients with myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Clinical decision-making and treatment of myelodysplastic syndromes |
|
American Journal of Hematology |
Myelodysplastic Syndromes (MDS) |
| Diagnosis and classification of myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Long-term efficacy and safety of romiplostim in refractory aplastic anemia: follow-up of a phase 2/3 study |
|
Blood Advances |
Aplastic Anemia |
| Experience of life quality from patients with aplastic anemia: a descriptive qualitative study |
|
Orphanet Journal of Rare Diseases |
Aplastic Anemia |
| Efficacy of complement inhibitors for patients with paroxysmal nocturnal hemoglobinuria: a systematic review and meta-analysis |
|
Therapeutic Advances in Hematology |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Plain language summary of RACE study results: addition of eltrombopag to standard treatment of severe aplastic anemia |
|
Immunotherapy |
Aplastic Anemia |
| Granulocyte transfusions in severe aplastic anemia |
|
Haematologica |
Aplastic Anemia |
